Menu
My Activity Hub
Podcasts
Videos
Pricing
Feedback
Tutoring
Sign Up
Log In
My Activity Hub
Podcasts
Videos
How it works
Pricing
Tutoring
Sign Up
Log In
OncLive® On Air
Garcia-Manero on MDS Treatment Updates With Luspatercept and Beyond
15 mins; August 19, 2024
FDA Approval Insights: Durvalumab/Chemotherapy in dMMR Advanced Endometrial Cancer
9 mins; August 15, 2024
ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo vs Adjuvant Nivo for Resectable Stage III Melanoma
10 mins; August 12, 2024
Rotow Reviews Key Updates on the Management of CNS Metastases in NSCLC
10 mins; August 08, 2024
Park and Grivas Expand on Treatment Updates in Bladder Cancer
16 mins; August 07, 2024
Halmos on the AE Profiles of Dato-DXd and Other ADCs in NSCLC
10 mins; August 05, 2024
Lisberg Lends Insight About the TROPION-Lung01 Trial of Dato-DXd in NSCLC
12 mins; August 01, 2024
Pegram Details the Use of Oral SERDs in ESR1+ Metastatic Breast Cancer
11 mins; July 29, 2024
Miller Discusses the Use of Selinexor in TP53 Wild-Type Advanced Endometrial Cancer
11 mins; July 25, 2024
Park and Sonpavde on Sacituzumab Govitecan Plus Enfortumab Vedotin in Metastatic Urothelial Cancer
22 mins; July 24, 2024
Bui and Kelly Discuss the Utility of Nab-Sirolimus in Advanced Malignant PEComa
17 mins; July 18, 2024
Curigliano on the DESTINY-Breast06 Trial in HER2-Low and -Ultralow Metastatic Breast Cancer
10 mins; July 15, 2024
Orlowski on Isa-VRd in Transplant-Ineligible Multiple Myeloma
10 mins; July 11, 2024
Park and Sonpavde on Nivolumab Plus Gemcitabine/Cisplatin in Cisplatin-Eligible Urothelial Cancer
7 mins; July 10, 2024
ASCO 2024 Plenary: ADRIATIC Trial in Limited-Stage Small Cell Lung Cancer
12 mins; July 08, 2024
FDA Approval Insights: Imetelstat in Lower-Risk MDS and Transfusion-Dependent Anemia
7 mins; July 01, 2024
Dietrich and Shiller Dive Into the Importance of Oncology Reflex Testing
18 mins; June 27, 2024
Agulnik Highlights Key Updates in GIST Research and Management
16 mins; June 24, 2024
Reckamp Discusses the Integration of Pragmatic Elements Into Oncology Clinical Trial Designs
9 mins; June 20, 2024
Rosenberg Reviews the Evolving Role of Toripalimab in Nasopharyngeal Carcinoma
17 mins; June 17, 2024
ASCO 2024 Plenary: LAURA Trial in Unresectable Stage III EGFRm NSCLC
12 mins; June 10, 2024
Paik Provides Insights Into Tepotinib Treatment in NSCLC Harboring MET Exon 14 Skipping Alterations
13 mins; June 06, 2024
Lenz Discusses the Prognostic and Predictive Value of HER2 Gene Expression in KRAS Wild-Type mCRC
13 mins; June 03, 2024
Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC
10 mins; May 30, 2024
Park and Sonpavde on Considerations for Enfortumab Vedotin Plus Pembrolizumab in Bladder Cancer
10 mins; May 30, 2024
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
16 mins; May 23, 2024
Ganjoo Discusses Treatment Plans, Patient Conversations, and the Role of Nab-Sirolimus in Malignant PEComa
12 mins; May 20, 2024
Brown Highlights the Rationale for the RAMP-301 Trial in Low-Grade Serous Ovarian Cancer
7 mins; May 13, 2024
Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors
13 mins; May 09, 2024
Goy Gives Insights Into the Future Management of Lymphoma and Multiple Myeloma
16 mins; May 06, 2024
Merkow and Connell Highlight Considerations for HAI Pump Use in CRC
24 mins; May 02, 2024
Bou Farhat and Nassar on the Use of NGS Mutation Signature vs IHC for Identifying dMMR Tumors
25 mins; April 29, 2024
FDA Approval Insights: Cilta-Cel in R/R Myeloma After at Least 1 Prior Line of Therapy
9 mins; April 22, 2024
Lunning and Rutherford Detail Considerations for BV-AVD Use in Older Patients With Hodgkin Lymphoma
13 mins; April 18, 2024
Breast Cancer Experts Share Obstacles and Successes as Women in Oncology
42 mins; April 11, 2024
FDA Approval Insights: Ponatinib in Ph+ ALL
9 mins; April 08, 2024
Schmid Summarizes Updates in HER2-Positive Breast Cancer Management
14 mins; April 01, 2024
Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa
15 mins; March 28, 2024
CRC Experts Highlight AE Management and Prevention Strategies for TAS-102/Bevacizumab, Regorafenib, and Fruquintinib
35 mins; March 25, 2024
Bagley Summarizes the ACTION trial of ONC201 in H3 K27M–Mutant Diffuse Midline Gliomas
13 mins; March 21, 2024
Lunning and Herrera Highlight Frontline Hodgkin Lymphoma Management Strategies
14 mins; March 18, 2024
FDA Approval Insights: NALIRIFOX in Metastatic Pancreatic Cancer
7 mins; March 11, 2024
Dr Kyriakopoulos on the Investigation of Masofaniten Plus Enzalutamide in mCRPC
11 mins; March 07, 2024
Kang Highlights Considerations for the Integration of Toripalimab into Nasopharyngeal Carcinoma Clinical Practice
8 mins; February 29, 2024
Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS
10 mins; February 26, 2024
Tripathy Talks Through the Enduring Impact of the Miami Breast Cancer Conference
16 mins; February 22, 2024
Kitco and Patel Emphasize the Importance of GVHD Research and Awareness
15 mins; February 19, 2024
FDA Approval Insights: Enfortumab Vedotin Plus Pembrolizumab in Locally Advanced/Metastatic Urothelial Carcinoma
9 mins; February 12, 2024
Community Oncologists on the Importance of Self-Reliance and Collegial Trust as Women in Medicine
22 mins; February 08, 2024
Lunning and Brander Emphasize the Importance of Early CLL Diagnosis and Treatment
14 mins; February 05, 2024
Expert and Patient Perspectives on AE Management With FGFR Inhibitors in Cholangiocarcinoma
16 mins; January 29, 2024
FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL
10 mins; January 25, 2024
Lunning and Maddocks Talk Through Frontline MCL Management
14 mins; January 22, 2024
FDA Approval Insights: Nirogacestat in Progressing Desmoid Tumors Requiring Systemic Treatment
7 mins; January 15, 2024
Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers
21 mins; January 11, 2024
Donington and Stiles Summarize NSCLC Resectability Parameters and Multidisciplinary Management
11 mins; January 08, 2024
FDA Approval Insights: Capivasertib Plus Fulvestrant in Advanced HR+/HER2- Breast Cancer With PIK3CA, AKT1, or PTEN Alterations
14 mins; January 04, 2024
Santos Summarizes Key Updates From EMPOWER-Lung 1 and EMPOWER-Lung 3 With Cemiplimab in NSCLC
15 mins; January 01, 2024
Jabbour Reports Top Takeaways From ASH 2023 of Olverembatinib in CML and ALL
8 mins; December 28, 2023
Eskander Emphasizes the Importance of Inclusivity and Accessibility in Oncology Clinical Trials
13 mins; December 25, 2023
Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL
17 mins; December 21, 2023
Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors
25 mins; December 18, 2023
Donington and Stiles Describe the Surgical Implications of Lung Cancer Treatment Evolutions
11 mins; December 11, 2023
Abdou Spotlights Factors Influencing ADC Treatment Selection in Breast Cancer
14 mins; December 07, 2023
FDA Approval Insights: Toripalimab in Recurrent/Metastatic Nasopharyngeal Carcinoma
17 mins; December 04, 2023
Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma
15 mins; November 30, 2023
Dumbrava Details Ongoing Research With PC14586 in p53 Y220C–Mutated Advanced Solid Tumors
10 mins; November 23, 2023
FDA Approval Insights: Ivosidenib in R/R IDH1+ Myelodysplastic Syndrome
8 mins; November 20, 2023
Halmos Highlights Evaluation of the EGFR Inhibitor BDTX-1535 in NSCLC
13 mins; November 16, 2023
Feigin Discusses the Association Between Benzodiazepines and Pancreatic Cancer Outcomes
11 mins; November 13, 2023
Khouri Highlights the Ongoing AFFIRM-AL Trial in AL Amyloidosis
13 mins; November 09, 2023
FDA Approval Insights: Adjuvant Nivolumab in Completely Resected Stage IIB/C Melanoma
11 mins; November 06, 2023
Lunning and Nastoupil Highlight Treatment Considerations and Ongoing Research in Follicular Lymphoma
15 mins; October 30, 2023
Naumann Discusses Notable Research Efforts in Endometrial Cancer
7 mins; October 26, 2023
Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection
9 mins; October 23, 2023
Hasanuma Highlights the Benefits of Building Authentic Connections Through Mentorship
16 mins; October 19, 2023
FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia
12 mins; October 16, 2023
Gutierrez and Leslie Discuss Recent Efforts and Future Advances in CAR T-Cell Therapy
15 mins; October 12, 2023
Expert Insights on the United States Chemotherapy Shortage
15 mins; October 09, 2023
FDA Approval Insights: First-Line Luspatercept for Anemia in Lower-Risk MDS
10 mins; October 05, 2023
Richardson Reviews Findings and Future Directions With Mezigdomide Plus Dexamethasone in R/R Myeloma
24 mins; October 02, 2023
Garcia-Manero and Zeidan Highlight Key Implications of the COMMANDS Trial in Lower-Risk MDS
30 mins; September 28, 2023
FDA Approval Insights: Elranatamab in Relapsed/Refractory Multiple Myeloma
18 mins; September 21, 2023
Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST
21 mins; September 18, 2023
Chuong Discusses the Importance of MRI-Guided Radiotherapy in Cancer
15 mins; September 14, 2023
Fonkoua Sheds Light on Liver Cancer Clinical Trial Disparities
15 mins; September 11, 2023
FDA Approval Insights: Talquetamab in Relapsed/Refractory Multiple Myeloma
15 mins; September 07, 2023
Usmani Highlights the Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
14 mins; September 04, 2023
Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC
14 mins; August 31, 2023
Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST
21 mins; August 31, 2023
FDA Approval Insights: Dostarlimab Plus Chemotherapy in dMMR/MSI-H Advanced Endometrial Cancer
11 mins; August 28, 2023
Camidge and Vokes Reflect on Research Journeys, Team Building, and Mentorship
48 mins; August 24, 2023
FDA Approval Insights: Quizartinib in Newly Diagnosed, FLT3-ITD+ AML
10 mins; August 21, 2023
Trent Breaks Down Mutation Testing and ctDNA Monitoring in GIST
8 mins; August 17, 2023
Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML
13 mins; August 14, 2023
Sanai Spotlights Meningioma Symptoms, Treatment Options, and Research Needs
20 mins; August 10, 2023
Danish Discusses the Benefits of SCINTIX Biology-Guided Radiotherapy in Metastatic Lung and Bone Cancers
14 mins; August 07, 2023
FDA Approval Insights: Glofitamab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
21 mins; August 03, 2023
Trent Talks Through Potential Clinical Applications and Future Directions for MRD in GIST
10 mins; July 31, 2023
Camidge and Abbott Discuss the Role of the Biotechnology Analyst in Drug Development
42 mins; July 27, 2023
Click here to see more
‹ Prev
1
2
3
4
5
6
Next ›
